Evaluation of methotrexate toxicity

dc.contributor.authorРябенко, Тетяна Василівна
dc.contributor.authorRiabenko, Tetiana Vasylivna
dc.contributor.authorГула, Вікторія Іванівна
dc.contributor.authorHula, Viktoriia Ivanivna
dc.contributor.authorКореньков, Олексій Володимирович
dc.contributor.authorKorenkov, Oleksii Volodymyrovych
dc.contributor.authorПонирко, Аліна Олексіївна
dc.contributor.authorPonyrko, Alina Oleksiivna
dc.contributor.authorТеслик, Тетяна Петрівна
dc.contributor.authorTeslyk, Tetiana Petrivna
dc.contributor.authorДмитрук, Сергій Миколайович
dc.contributor.authorDmytruk, Serhii Mykolaiovych
dc.contributor.authorІлляшенко, Вячеслав Юрійович
dc.contributor.authorIlliashenko, Viacheslav Yu.
dc.contributor.authorДудченко, Євгеній Сергійович
dc.contributor.authorDudchenko, Yevhenii Serhiiovych
dc.date.accessioned2024-05-13T07:33:29Z
dc.date.available2024-05-13T07:33:29Z
dc.date.issued2023
dc.description.abstractThe article analyzes literary sources on the study of the toxic effects of methotrexate in the treatment of various diseases and examines scientific data on methods of preventing their development. According to the literary information, the main toxic effects of methotrexate manifest as damage to the liver, kidneys, bone marrow, lungs, digestive system, and skin. Methotrexate exhibits pronounced embryotoxic and teratogenic effects. Monitoring of blood test parameters and selection of an optimal dose will minimize methotrexate toxic effects and help in achieving success in the treatment.en_US
dc.identifier.citationRiabenko T. V., Hula V. I., Korenkov O. V., Ponyrko A. A., Teslyk T. P. et al. Evaluation of methotrexate toxicity. Azerbaijan Medical Journal. 2023;(4).141-146. DOI: 10.34921/amj.2023.4.020.en_US
dc.identifier.urihttps://essuir.sumdu.edu.ua/handle/123456789/95266
dc.language.isouken_US
dc.publisherIzdatel'stvo Elmen_US
dc.rights.uriCC BY 4.0en_US
dc.subjectmethotrexateen_US
dc.subjecttoxisityen_US
dc.subjectside effectsen_US
dc.subjectclinical evaluationen_US
dc.subjectbone marrow diseaseen_US
dc.subjectteratogenesisen_US
dc.subjectdigestive system diseaseen_US
dc.subjectembryotoxicityen_US
dc.subjectskin diseaseen_US
dc.subjectlung diseaseen_US
dc.subjectliver diseaseen_US
dc.subjectkidney diseaseen_US
dc.titleEvaluation of methotrexate toxicityen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Riabenko_methotrexate_2023.pdf
Size:
373.49 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.96 KB
Format:
Item-specific license agreed upon to submission
Description: